Arsani William - 10 Jun 2025 Form 4 Insider Report for Design Therapeutics, Inc. (DSGN)

Role: Director
Signature: /s/ Mustapha Parekh, Attorney-in-Fact
Issuer symbol: DSGN
Transactions as of: 10 Jun 2025
Transactions value $: $0
Form type: 4
Filing time: 12 Jun 2025, 16:30:20 UTC
Previous filing: 12 Aug 2024
Next filing: 14 Aug 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
William Arsani	Director	C/O DESIGN THERAPEUTICS, INC., 6005 HIDDEN VALLEY ROAD, SUITE 110, CARLSBAD	/s/ Mustapha Parekh, Attorney-in-Fact	12 Jun 2025	0001848372

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DSGN	Stock Option (right to buy)	Award	$0	+19K		$0.00	19K	10 Jun 2025	Common Stock	19K	$4.01	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option vest in equal monthly installments over 12 months following June 10, 2025 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders.